We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,404

The PRC Mental Health Law came into force
  • King & Wood Mallesons
  • China
  • May 20 2013

The PRC Mental Health Law (the "Mental Health Law") came into force on May 1, 2013. For the purpose of the Mental Health Law, "mental disorders"


China publishes revised good supply practice (GSP) standards for pharmaceutical products
  • Clifford Chance LLP
  • China
  • May 20 2013

After several years of drafting and three rounds of public consultation, the Ministry of Health has at last published the revised Good Supply


Regulation of medical advertisements
  • Clyde & Co LLP
  • China
  • April 30 2013

With over 1.35 billion people, healthcare in China is already a huge, and growing, market. Companies seeking to develop this potential have used


Updated rules on registration of medical devices in China
  • CMS Cameron McKenna
  • China
  • October 20 2014

As a consequence of the introduction of the new Regulation on the Supervision and Administration of Medical Devices ("New Regulation"), effective


Updated rules on registration of medical devices more stringent requirements for foreign medical device companies
  • CMS, China
  • China
  • October 20 2014

As a consequence of the introduction of the new Regulation on the Supervision and Administration of Medical Devices ("New Regulation"), effective


Gilead’s Viread patent found invalid in China
  • Marks & Clerk
  • China
  • December 17 2013

Earlier this year, the Patent Review Board of China's State Intellectual Property Office (SIPO) rejected Gilead Sciences' claims regarding their


China tightens controls over commercial bribery in the health care industry -
  • Ropes & Gray LLP
  • China, USA
  • January 3 2014

As of March 1, 2014, the China National Health and Family Planning Commission (the "Commission") will compile bribery blacklists in the health care


China strengthens anti-corruption requirements and highlights risks for pharmaceutical and medical device companies
  • Sidley Austin LLP
  • China
  • January 2 2014

On December 26, 2013, China's National Health and Family Planning Commission (NHFPC) issued a Notice on "Nine Prohibitions" to Strengthen


WHO reports first documented human case of avian influenza A
  • Shook Hardy & Bacon LLP
  • USA, China
  • December 20 2013

The World Health Organization (WHO) has reported the first documented case of avian influenza A (H10N8) in a human patient from Jiangxi Province


China amends its pharmaceutical and medical device blacklist system
  • Sidley Austin LLP
  • China
  • January 2 2014

On December 27, 2013, China's National Health and Family Planning Commission (NHFPC) published the amended Provisions for Establishing Bad Records